Hasil Pencarian - Kenneth C. Anderson

Perbaiki Hasil
  1. 1
    Should minimal residual disease negativity be the end point of myeloma therapy?

    Should minimal residual disease negativity be the end point of myeloma therapy? oleh Kenneth C. Anderson

    Diterbitkan 2017-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Multiple myeloma: the (r)evolution of current therapy and a glance into future

    Multiple myeloma: the (r)evolution of current therapy and a glance into future oleh Annamaria Gulla, Kenneth C. Anderson

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Author Correction: The biological significance of histone modifiers in multiple myeloma: clinical applications

    Author Correction: The biological significance of histone modifiers in multiple myeloma: clinical applications oleh Hiroto Ohguchi, Teru Hideshima, Kenneth C. Anderson

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    New Frontiers in the Treatment of Multiple Myeloma

    New Frontiers in the Treatment of Multiple Myeloma oleh Janice Jin Hwang, Irene M. Ghobrial, Kenneth C. Anderson

    Diterbitkan 2006-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy

    Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy oleh Shih-Feng Cho, Shih-Feng Cho, Shih-Feng Cho, Shih-Feng Cho, Kenneth C. Anderson, Kenneth C. Anderson, Yu-Tzu Tai, Yu-Tzu Tai

    Diterbitkan 2018-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today’s treat-to-target era

    Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today’s treat-to-target era oleh Li Zhang, Yu-Tzu Tai, Matthew Zhi Guang Ho, Lugui Qiu, Kenneth C. Anderson

    Diterbitkan 2017-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1

    Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1 oleh Yu-Tzu Tai, Shih-Feng Cho, Shih-Feng Cho, Shih-Feng Cho, Kenneth C. Anderson

    Diterbitkan 2018-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Identification and validation of ecto-5' nucleotidase as an immunotherapeutic target in multiple myeloma

    Identification and validation of ecto-5' nucleotidase as an immunotherapeutic target in multiple myeloma oleh Arghya Ray, Yan Song, Ting Du, Leutz Buon, Yu-Tzu Tai, Dharminder Chauhan, Kenneth C. Anderson

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myeloma

    BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myeloma oleh Debasmita Dutta, Jiye Liu, Kenneth Wen, Keiji Kurata, Mariateresa Fulciniti, Annamaria Gulla, Teru Hideshima, Kenneth C. Anderson

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Monoclonal Antibody: A New Treatment Strategy against Multiple Myeloma

    Monoclonal Antibody: A New Treatment Strategy against Multiple Myeloma oleh Shih-Feng Cho, Liang Lin, Lijie Xing, Tengteng Yu, Kenneth Wen, Kenneth C. Anderson, Yu-Tzu Tai

    Diterbitkan 2017-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13

    Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13 oleh Yan Song, Ting Du, Arghya Ray, Krishan Chauhan, Mehmet Samur, Nikhil Munshi, Dharminder Chauhan, Kenneth C. Anderson

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Bispecific antibodies in multiple myeloma treatment: A journey in progress

    Bispecific antibodies in multiple myeloma treatment: A journey in progress oleh Shih-Feng Cho, Shih-Feng Cho, Shih-Feng Cho, Tsung-Jang Yeh, Kenneth C. Anderson, Yu-Tzu Tai

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Meaningful changes in end-of-life care among patients with myeloma

    Meaningful changes in end-of-life care among patients with myeloma oleh Oreofe O. Odejide, Ling Li, Angel M. Cronin, Anays Murillo, Paul G. Richardson, Kenneth C. Anderson, Gregory A. Abel

    Diterbitkan 2018-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    The challenge of cross-trial comparisons using limited data

    The challenge of cross-trial comparisons using limited data oleh Jacob P. Laubach, Edward A. Faber, Peter Voorhees, Javid Moslehi, Cindy Varga, Liviu Niculescu, Kenneth C. Anderson, Paul G. Richardson

    Diterbitkan 2014-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma

    Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma oleh Jana Jakubikova, Danka Cholujova, Gabor Beke, Teru Hideshima, Lubos Klucar, Merav Leiba, Krzysztof Jamroziak, Paul G. Richardson, Efstathios Kastritis, David M. Dorfman, Kenneth C. Anderson

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Gene Expression Profiling in Multiple Myeloma: Redefining the Paradigm of Risk-Adapted Treatment

    Gene Expression Profiling in Multiple Myeloma: Redefining the Paradigm of Risk-Adapted Treatment oleh Claudio Cerchione, Saad Z. Usmani, A. Keith Stewart, Martin Kaiser, Martin Kaiser, Leo Rasche, Martin Kortüm, María-Victoria Mateos, Andrew Spencer, Pieter Sonneveld, Kenneth C. Anderson

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: implications for clinical translation.

    Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: implications for clinical translation. oleh Douglas W McMillin, Jake Delmore, Joseph Negri, Melissa Ooi, Steffen Klippel, Chandrasekhar V Miduturu, Nathanael S Gray, Paul G Richardson, Kenneth C Anderson, Andrew L Kung, Constantine S Mitsiades

    Diterbitkan 2011-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation

    γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation oleh Hailin Chen, Tengteng Yu, Liang Lin, Lijie Xing, Shih-Feng Cho, Kenneth Wen, Kimberly Aardalen, Adwait Oka, Joni Lam, Mike Daley, Haihui Lu, Nikhil Munshi, Kenneth C. Anderson, Yu-Tzu Tai

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors

    In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors oleh Anil Aktas Samur, Mariateresa Fulciniti, Herve Avet-Loiseau, Michael A. Lopez, Sanika Derebail, Jill Corre, Stephane Minvielle, Florence Magrangeas, Philippe Moreau, Kenneth C. Anderson, Giovanni Parmigiani, Mehmet K. Samur, Nikhil C. Munshi

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Longitudinal genetically detectable minimal residual disease by fluorescence hybridization confers a poor prognosis in myeloma

    Longitudinal genetically detectable minimal residual disease by fluorescence hybridization confers a poor prognosis in myeloma oleh Jian Cui, Tengteng Yu, Rui Lv, Jiahui Liu, Huishou Fan, Wenqiang Yan, Jingyu Xu, Chenxing Du, Shuhui Deng, Weiwei Sui, Matthew Ho, Yan Xu, Kenneth C. Anderson, Xifeng Dong, Lugui Qiu, Gang An

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: